NCT03167164 2025-02-21QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 TherapyImmunityBio, Inc.Phase 1/2 Withdrawn
NCT04874831 2021-11-18Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1)4SC AGPhase 2 Withdrawn